Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lower Chloride Fluids in Critical Illness
NCT00885404Phase 4Unknown
- Sponsor
- Austin Health
- Start
- Feb 2009
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of lactated ringer's solution and plasmalyte in Shock and critical illness (2 arms), sponsored by Austin Health. Primary endpoint: Mean Base Excess. Status: unknown.
02
Drugs
lactated ringer's solutionplasmalyte
03
Conditions
Shockcritical illness
Beyond the preview
Go deeper on NCT00885404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00885404.